REBECCA ELLWOOD: Open Payments
NPI 1518100403 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160,658 in 389 payments from 25 companies in 2025. Trend: 2023 $99,429 · 2024 $116,521 · 2025 $160,658
Speaker / faculty: $99,037Travel & lodging: $46,245Speaker / faculty: $8,353Food & beverage: $7,023
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 62 | $55,523 |
| Lilly USA, LLC | 104 | $35,802 |
| Novo Nordisk Inc | 46 | $31,287 |
| Abbott Laboratories | 45 | $18,692 |
| Insulet Corporation | 59 | $17,594 |
| Sequel Med Tech, LLC | 1 | $214 |
| Medtronic, Inc. | 2 | $210 |
| Dexcom, Inc. | 11 | $197 |
| Amgen Inc. | 12 | $172 |
| Radius Health, Inc. | 7 | $172 |
Products named: TZIELD, MOUNJARO, Ozempic, FREESTYLE LIBRE 3, OMNIPOD, Wegovy, TWIIST, MINIMED 780G.
Industry payments across NY — which companies pay providers there.
